Very-Low-Calorie Ketogenic Diets With Whey, Vegetable, or Animal Protein in Patients With Obesity: A Randomized Pilot Study - PubMed (original) (raw)

Randomized Controlled Trial

. 2020 Sep 1;105(9):dgaa336.

doi: 10.1210/clinem/dgaa336.

Elisabetta Camajani [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Savina Contini [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Agnese Persichetti 2, Renata Risi [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Loris Bertoldi 3, Lidia Strigari 4, Giancarlo Prossomariti [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Mikiko Watanabe [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Stefania Mariani [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Carla Lubrano [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Alfredo Genco [ 5](#full-view-affiliation-5 "Department of Surgical Sciences, Surgical Endoscopy Unit, University of Rome "La Sapienza," Rome, Italy."), Giovanni Spera [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy."), Lucio Gnessi [ 1](#full-view-affiliation-1 "Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy.")

Affiliations

Randomized Controlled Trial

Very-Low-Calorie Ketogenic Diets With Whey, Vegetable, or Animal Protein in Patients With Obesity: A Randomized Pilot Study

Sabrina Basciani et al. J Clin Endocrinol Metab. 2020.

Abstract

Context: We compared the efficacy, safety, and effect of 45-day isocaloric very-low-calorie ketogenic diets (VLCKDs) incorporating whey, vegetable, or animal protein on the microbiota in patients with obesity and insulin resistance to test the hypothesis that protein source may modulate the response to VLCKD interventions.

Subjects and methods: Forty-eight patients with obesity (19 males and 29 females, homeostatic model assessment (HOMA) index ≥ 2.5, aged 56.2 ± 6.1 years, body mass index [BMI] 35.9 ± 4.1 kg/m2) were randomly assigned to three 45-day isocaloric VLCKD regimens (≤800 kcal/day) containing whey, plant, or animal protein. Anthropometric indexes; blood and urine chemistry, including parameters of kidney, liver, glucose, and lipid metabolism; body composition; muscle strength; and taxonomic composition of the gut microbiome were assessed. Adverse events were also recorded.

Results: Body weight, BMI, blood pressure, waist circumference, HOMA index, insulin, and total and low-density lipoprotein cholesterol decreased in all patients. Patients who consumed whey protein had a more pronounced improvement in muscle strength. The markers of renal function worsened slightly in the animal protein group. A decrease in the relative abundance of Firmicutes and an increase in Bacteroidetes were observed after the consumption of VLCKDs. This pattern was less pronounced in patients consuming animal protein.

Conclusions: VLCKDs led to significant weight loss and a striking improvement in metabolic parameters over a 45-day period. VLCKDs based on whey or vegetable protein have a safer profile and result in a healthier microbiota composition than those containing animal proteins. VLCKDs incorporating whey protein are more effective in maintaining muscle performance.

Trial registration: ClinicalTrials.gov NCT04019431.

Keywords: VLCKD; animal proteins; intestinal microbiota; obesity; therapy; vegetable proteins; very low calorie ketogenic diet; whey proteins.

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources